Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Clinical trial NCT02932280 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02932280
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2026-10-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.